Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celebrex and Metformin for Postoperative Hepatocellular Carcinoma
NCT03184493Phase 3Unknown
- Sponsor
- Guangxi Medical University
- Start
- Jun 2017
- Primary completion
- Dec 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of celecoxib, metformin in hepatocellular carcinoma (HCC), sponsored by Guangxi Medical University. Status: unknown.
02
Drugs
celecoxibmetformin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT03184493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03184493.